Top

Published in:

01-09-2016 | Original Article

Bisphosphonate-related osteonecrosis of the jaw: a review of the potential efficacy of low-level laser therapy

Authors: S. Latifyan, M. T. Genot, J. Klastersky

Published in: Supportive Care in Cancer | Issue 9/2016

Abstract

Osteonecrosis of the jaw (ONJ) resulting from administration of bisphosphonates (BP) or denosumab is a rare but severe complication in cancer patients. Complete remission depends on the stage of ONJ; it can be estimated in the range of 20–30 %. Low-level laser therapy (LLLT) is a logical additional option, as it has been recognized effective for the management of chemotherapy and/or radiotherapy-induced mucositis. LLLT irradiation has anti-inflammatory actions and thus can help to control pain, as well as biostimulating properties with favorable actions on bacterial control and wound healing. We review the results of seven published studies of LLLT in BP-associated ONJ. LLLT results in an overall response rate of 55 % superior to that observed in controls (30 %). Our review suggests that there might be an advantage to add LLLT to the “classical” management of ONJ. This therapy is easy to administer and is not associated with any known side effects. Further research is needed to remove any doubt of protection or enhancement of carcinogenic processes. We believe that prospective well-controlled studies of LLLT in ONJ are warranted. If the positive results are confirmed, it would represent a great improvement for the quality of life of many patients.

Lee S-H et al. (2014) Use of bisphosphonates and the risk of osteonecrosis among cancer patients: a systemic review and meta-analysis of the observational studies. Support Care Cancer 22:553–560CrossRefPubMed

Campisi G et al. (2007) Bisphosphonate-related osteonecrosis of the jaw (BRONJ): run dental management designs and issues in diagnosis. Ann Oncol 18(6):vi168–vi172PubMed

Migliorati CA et al. (2011) Osteonecrosis of the jaw and bisphosphonates in cancer: a narrative review, Nature 2011. Nat Rev Endocrinol 7:34–42CrossRefPubMed

American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws. Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws. J Oral Maxillofac Surg 2007; 65: 369

Ruggiero SL et al. (2009) Bisphosphonate-related osteonecrosis of the Jaw: Diagnosis, prevention, and management. Annu Rev Med 60:85–96CrossRefPubMed

Vescovi P et al. (2010) Bisphosphonate-related osteonecrosis of the jaw (BRONJ) therapy. A critical review. Minerva Stomatol 59(4):181–213PubMed

Vescovi P et al. (2012) Bisphosphonate-related osteonecrosis of the jaws: a concise review of the literature and a report of a single-centre experience with 151 patients. J Oral Pathol Med 41:214–221CrossRefPubMed

Atalay B et al. (2011) Bisphosphonate-related osteonecrosis: laser-assisted surgical treatment or conventional surgery? Lasers Med Sci 26(6):815–823CrossRefPubMed

Romeo U et al. (2011) Observation of pain control in patients with bisphosphonate-induced osteonecrosis using low level laser therapy: preliminary results. Photomed Laser Surg 29(7):447–452CrossRefPubMed

10.

Scoletta M et al. (2010) Effect of low-level laser irradiation on bisphonate-induced osteonecrosis of the jaws: preliminary results of a prospective study. Photomed Laser Surg 28(2):179–184CrossRefPubMed

11.

Martins MAT et al. (2012) Association of laser phototherapy with PRP improves healing of bisphosphonate-related osteonecrosis of the jaws in cancer patients: a preliminary study. Oral Oncol 48:79–84CrossRefPubMed

12.

Altay MA et al. (2014) Low-level laser therapy supported surgical treatment of bisphosphonate related osteonecrosis of jaws: a retrospective analysis of 11 cases. Photomed Laser Surg 32(8):468–475CrossRefPubMed

13.

Angiero F et al. (2009) Osteonecrosis of the jaws caused by bisphosphonates: evaluation of a new therapeutic approach using the Er: YAG laser. Lasers Med Sci 24(6):849–856CrossRefPubMed

14.

Vescovi P et al. (2013) Case series of 589 tooth extractions in patients under bisphosphonates therapy, Proposal of a clinical protocol supported by Nd: YAG low-level laser therapy. Med Oral Patol Oral Cir Bucal 18(4):e680–e685CrossRefPubMedPubMedCentral

15.

Vescovi P et al. (2014) Conservative surgical management of stage I bisphosphonate-related osteonecrosis of the jaw. Int J Dent 2014:107690CrossRefPubMedPubMedCentral

16.

Stübinger S et al. (2007) Le laser Er: YAG dans le domaine de la chirurgie dento-alvéolaire. Rev Mens Suisse Odontostomatol 117(11):1144–1146

17.

Gerbi ME et al. (2008) Infrared laser light further improves bone healing when associated with bone morphogenic proteins: An in vivo study in a rodent model. Photomed Laser Surg 26(1):55–60CrossRefPubMed

18.

Lee JY et al. (2015) Effect of low-level laser therapy on oral keratinocytes exposed to bisphosphonate. Lasers Med Sci 30(2):635–643CrossRefPubMed

19.

Genot-Klastersky MT et al. (2008) The use of low-energy laser (LEL) for the prevention of chemotherapy-and/or radiotherapy-induced oral mucositis in cancer patients: results from two prospective studies. Support Care Cancer 16:1381–1387CrossRefPubMed

20.

Peterson DE et al. (2011) ESMO Guidelines working group. Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines. Ann Oncol 6:vi78–vi84

21.

Lalla RV et al. (2014) Mucositis guidelines leadership group of the multinational association of supportive care in cancer and international society of oral oncology. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 120(10):1453–1461CrossRefPubMedPubMedCentral

22.

Mester E, Mester AF, Mester A (1985) The biomedical effects of laser application. Lasers Surg Med 5:31–39CrossRefPubMed

23.

Karu TI (1988) Molecular mechanism of the therapeutic effect of low-intensity laser radiation. Lasers Life Sci 2:53–74

24.

Zhang Y, Song S, Fong CC, Tsang CH, Yang Z, Yang M (2003) cDNA microarray analysis of gene expression profiles in human fibroblast cells irradiated with red light. J Investig Dermatol 120:849–857CrossRefPubMed

25.

Garavello-Freitas I, Baranauskas V, Joazeiro PP, et al. (2003) Low-power laser irradiation improves histomorphometrical parameters and bone matrix organization during tibia wound healing in rats. J Photochem Photobiol B 70:81–89CrossRefPubMed

26.

Yu HS, Chang KL, Yu CL, Chen JW, Chen GS (1996) Low-energy helium-neon laser irradiation stimulates interleukin-1 alpha and interleukin-8 release from cultured human keratinocytes. J Investig Dermatol 107:593–596CrossRefPubMed

27.

Kipshidze N, Nikolaychik V, Keelan MH, Shankar LR, Khanna A, Kornowski R, Leon M, Moses J (2001) Low-power helium: neon laser irradiation enhances production of vascular endothelial growth factor and promotes growth of endothelial cells in vitro. Lasers Surg Med 28:355–364CrossRefPubMed

28.

Yu W, Naim JO, Lanzafame RJ (1994) The effect of laser irradiation on the release of bFGF from 3T3 fibroblasts. Photochem Photobiol 59:167–170CrossRefPubMed

29.

Maiya GA, Kumar P, Rao L (2005) “Effect of low intensity helium-neon (He–Ne) laser irradiation on diabetic wound healing dynamics”. Photomed Laser Surg 23(2):187–190CrossRefPubMed

30.

Pourreau-Schneider N, Ahmed A, Soudry M, Jacquemier J, Kopp F, Franquin JC, Martin PM (1990) Helium-neon laser treatment transforms fibroblasts into myofibroblasts. Am J Pathol 137:171–178PubMedPubMedCentral

31.

Rajaratnam S, Bolton P, Dyson M (1994) Macrophage responsiveness to laser therapy with varying pulsing frequencies. Laser Ther 6:107–112CrossRef

32.

Rochkind S, Leider-Trejo L, Nissan M, et al. (2007) Efficacy of 780-nm laser phototherapy on peripheral nerve regeneration after neurotube reconstruction procedure (double-blind randomized study). Photomed Laser Surg 25:137–143CrossRefPubMed

33.

Rochkind S, Drory V, Alon M, et al. (2007) Laser phototherapy (780 nm), a new modality in treatment of long-term incomplete peripheral nerve injury: a randomized double-blind placebo-controlled study. Photomed Laser Surg 25:436–442CrossRefPubMed

34.

Stein E, Koehn J, Sutter W, Wendtlandt G, Wanschitz F, Thurnher D, et al. (2008) Initial effects of low-level laser therapy on growth and differentiation of human osteoblast-like cells. Wien Klin Wochenschr 120(3–4):112–117CrossRefPubMed

35.

Yamamoto M, Tamura K, Hiratsuka K, Abiko Y (2001) Stimulation of MCM3 gene expression in osteoblast by low level laser irradiation. Lasers Med Sci 16(3):213–217CrossRefPubMed

36.

Hilal Bayrama, Halime Kenarb, Ferda Taşara, Vasıf Hasırcıb. Effect of low level laser therapy and zoledronate on the viability and ALP activity of Saos-2 cells; International Journal of Oral and Maxillofacial Surgery; 42/1; 01/2013, Pages 140–146

37.

Hagiwara S, Iwasaka H, Okuda K, Noguchi T (2007) GaAlAs (830 nm) low-level laser enhances peripheral endogenous opioid analgesia in rats. Lasers Surg Med 39(10):797–802CrossRefPubMed

38.

Albertini R, Villaverde AB, Aimbire F, Salgado MA, Bjordal JM, Alves LP, Munin E, Costa MS (2007) Anti-inflammatory effects of low-level laser therapy (LLLT) with two different red wavelengths (660 nm and 684 nm) in carrageenan-induced rat paw edema. J Photochem Photobiol B 89(1):50–55CrossRefPubMed

39.

Gal D, Chokshi SK, Mosseri M, Clarke RH, Isner JM (1992) Percutaneous delivery of low-level laser energy reverses histamine-induced spasm in atherosclerotic Yucatan microswine. Circulation 85(2):756–768CrossRefPubMed

40.

Huang TH, Yu Chuan L, Kao CT (2012) Low-level diode laser therapy reduces lipopolysaccharide (LPS)-induced bone cell inflammation. Lasers Med Sci 27(Issue 3):621–627CrossRefPubMed

41.

Gutknecht N, Franzen R, Schippers M, Lampert F (2004) Bactericidal effect of a 980- nm diode laser in the root canal wall dentin of bovine teeth. J Clin Laser Med Surg 22(1):9–13CrossRefPubMed

42.

Nussbaum EL, Lilge L, Mazzulli T (2002) Effects of 810 nm laser irradiation on in vitro growth of bacteria: comparison of continuous wave and frequency modulated light. Lasers Surg Med 31(5):343–351

43.

Saad F, Brown JE, Van Barrios Poznak C et al. (2012) Incidence, risk factors and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active controlled phase III in cancer patients with bone metastases. Ann Oncol 23:1341–1347

44.

Stopeck AT1, Lipton A, Body JJ et al. (2010) Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study. J Clin Oncol 28(35):5132–5139

45.

Sperandio FF, Giudice FS, Corrêa L et al. (2013) Low-level laser therapy can produce increased aggressiveness of dysplastic and oral cancer cell lines by modulation of Akt/mTOR signaling pathway. J Biophotonics 6(10):839–847

Title: Bisphosphonate-related osteonecrosis of the jaw: a review of the potential efficacy of low-level laser therapy
Authors: S. Latifyan
M. T. Genot
J. Klastersky
Publication date: 01-09-2016
Publisher: Springer Berlin Heidelberg
Published in: Supportive Care in Cancer / Issue 9/2016
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-016-3139-9

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 9/2016

Hyponatremia in solid-tumor cancer patients: uncertainty regarding the use of vaptans

Scalp cooling: a qualitative study to assess the perceptions and experiences of Australian patients with breast cancer

Randomized pilot trial of yoga versus strengthening exercises in breast cancer survivors with cancer-related fatigue

Successful management of chronic disseminated candidiasis in hematologic patients treated with high-dose liposomal amphotericin B: a retrospective study of the SEIFEM registry

Psychometric assessment of the Chinese version of the MASCC Antiemesis Tool (MAT) for measuring chemotherapy-induced nausea and vomiting

Breast cancer survivors suffer from persistent postmastectomy pain syndrome and posttraumatic stress disorder (ORTHUS study): a study of the palliative care working committee of the Turkish Oncology Group (TOG)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer